These 3 Stocks Sit at the Intersection of Industry and Energy. Buy Them Now and Hold Forever.

The article highlights three companies positioned to benefit from rising power demand driven by AI and industrial electrification: Navitas Semiconductor, Argan, and NuScale Power. Argan posted record 2025 revenue of $944 million and net income of $138 million, while its backlog rose from under $1 billion in 2024 to nearly $3 billion. Navitas saw 2025 revenue fall to $45.9 million from $83.3 million, but NuScale's small modular reactor pipeline could begin generating meaningful revenue around 2030 as customer interest builds.

Analysis

The common thread is not “energy” per se, but capex migration: customers are increasingly choosing to own the power stack rather than buy electrons from the grid. That favors AGX first because it monetizes the bottleneck with near-term backlog conversion, while SMR is a longer-duration call on the same behavior shift and NVTS is the most fragile expression of efficiency demand because it depends on cost curves improving enough to unlock adoption. In other words, AGX is a cash-flow beneficiary of urgency, SMR is an option on strategic autonomy, and NVTS is a materials-enabled enabler that still has to prove pricing power.

The second-order effect is that AI data-center growth is not just a demand story for compute, it is a demand story for physical power infrastructure, which should keep EPC, gas-turbine, switchgear, and grid-interconnect suppliers tight for 18-36 months. That creates a relative-value setup: the market may continue to overpay for the “picks and shovels” with visible backlog while underestimating how much of the SMR narrative is actually a financing/regulatory story, not a technology story. NuScale’s path likely trades more on contract announcements and policy signaling than on revenue, so the stock can re-rate on headlines long before fundamentals inflect.

The main risk is duration mismatch. AGX’s backlog can still be hit by project delays, cost overruns, or customer financing issues if rates stay elevated; NVTS can remain a value trap if GaN/SiC remains too expensive for mainstream industrial replacement cycles; SMR can stall for years if permitting, siting, and utility procurement remain slower than anticipated. Conversely, any sharp pullback in AI capex or easing of power prices would hit the whole basket, but AGX would likely be the quickest to de-rate because its multiple is already discounting a clean execution runway.

Contrarian take: the market may be too focused on the scarcity of electricity and not enough on substitution. If utility build-out accelerates faster than expected, the urgency premium in behind-the-meter solutions could compress, especially for SMR, which needs multiple approvals and large project financing to scale. The cleaner expression is to own the near-term monetizers of the power shortage and treat the nuclear modularity story as a venture-style call option rather than a core compounder.

Key Decisions for Investors

• Long AGX on 3-6 month horizon; buy on any post-earnings digestion or market-wide AI pullback. Risk/reward favors continued backlog conversion and margin durability, but trim if project slippage shows up in management commentary.
• Pair long AGX / short NVTS for 6-12 months. The trade expresses near-term monetization of the power bottleneck versus a lower-visibility adoption story that still depends on cost declines and end-market pull-through.
• Initiate a small, asymmetric long SMR via call options or a starter equity position for 12-24 months. Treat it as a headline-driven catalyst trade; upside comes from contract wins and policy support, while downside is long-duration execution and financing risk.
• Avoid chasing NVTS into strength; wait for evidence of sequential revenue stabilization before adding. If SiC/GaN pricing inflects or design-win disclosures accelerate, reassess, but until then the stock remains a lower-quality lever on the same theme.
• Use any broad selloff in infrastructure/energy-transition names to scale into AGX over NVTS and SMR, because AGX has the clearest line of sight to earnings, while the others require multiple future steps to compound.